Depression, Anxiety Associated with Osteocalcin, Cortisol in Hyperparathyroidism
Anxiety and depression in people with hyperparathyroidism may be related to levels of 2 key hormones in the body, according to researchers.
Home
No Evidence of Increased Suicidality With Common Antiseizure Drug Use
This meta-analysis aimed to evaluate whether there’s evidence that supports the FDA-mandated warning for increased suicidality risk with antiseizure drug usage among people with epilepsy.
The Impact of Communication Skills on the Patient-Provider Relationship and Patient Outcomes
Investigators reviewed the connection between communication skills and patient satisfaction and offered recommendations for improving the patient-provider relationship.
Low Vitamin D Levels Tied to Higher Risk for COVID-19 Infection
US Black women with lower serum levels of vitamin D (25[OH]D) may be at increased risk for COVID-19 infection.
Visual Impairment Associated With Elevated Dementia Risk
Visual treatments may provide modifiable risk factor for dementia.
Number of Psychological Comorbidities Linked to Worsening IBS Prognosis
Investigators aimed to determine whether a higher number of psychological comorbidities at baseline would exacerbate IBS prognosis in patients with Rome IV-defined IBS.
ADHD Linked to Alzheimer Disease Across Generations
There is an association for attention-deficit/hyperactivity disorder with Alzheimer disease and any dementia across generations.
Sustained Response to Pimavanserin Reduces Relapse Risk in Patients With Dementia-Related Psychosis
Can the continuation of pimavanserin help with managing dementia-related psychosis? Researchers report on the findings of the phase 3 HARMONY trial.
Fluoxetine Does Not Decrease Symptoms of Clinical Depression in Patients After a Stroke
Researchers performed a secondary analysis of the AFFINITY trial that assessed the effects of fluoxetine treatment on depression symptoms in patients who recently had a stroke.
Depression, MS May Have Synergistic Effect on Mortality Risk
Depression in multiple sclerosis (MS) may increase the risks for incident vascular disease and mortality, and the effects of depression and MS on all-cause mortality appear to be synergistic.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Depressive Disorder
Loading... 
Loading...